title: Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9).
authors.affiliation: Vitreous-Retina Service, Department of Ophthalmology, Cerrahpasa School of Medicine, Surp Pirgic Armenian Hospital, Istanbul University, Istanbul, Turkey. Electronic address: huseyinyetik@icloud.com.
authors.forename: Huseyin
authors.initials: H
authors.lastname: Yetik
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D017075:Laser Coagulation; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000628:therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized